PubMed

Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.

Koo YX, Tan DS, Tan IB, Tao M, Lim ST.

Ann Intern Med. 2009 May 5;150(9):655-6. No abstract available. PMID: 19414854 [PubMed - indexed for MEDLINE]Related articlesFree article

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.

Yang SH, Kuo SH.

Ann Hematol. 2008 Apr;87(4):325-7. Epub 2007 Oct 12. No abstract available. PMID: 17932671 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.

J Clin Oncol. 2009 Feb 1;27(4):605-11. Epub 2008 Dec 15.PMID: 19075267 [PubMed - indexed for MEDLINE]Related articles

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.

Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.

Ann Hematol. 2004 Jan;83(1):58-60. Epub 2003 Sep 26.PMID: 14513286 [PubMed - indexed for MEDLINE]Related articles

Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.

Perceau G, Diris N, Estines O, Derancourt C, Lévy S, Bernard P.

Br J Dermatol. 2006 Nov;155(5):1053-6.PMID: 17034541 [PubMed - indexed for MEDLINE]Related articles

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.

Hernández JA, Diloy R, Salat D, del Río N, Martínez X, Castellví JM.

Haematologica. 2003 Jun;88(6):ECR22. No abstract available. PMID: 12801855 [PubMed - indexed for MEDLINE]Related articlesFree article

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM.

Ann Hematol. 2004 Dec;83(12):769-74. Epub 2004 Aug 25.PMID: 15338194 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.

Tsutsumi Y, Kawamura T, Saitoh S, Yamada M, Obara S, Miura T, Kanamori H, Tanaka J, Asaka M, Imamura M, Masauzi N.

Leuk Lymphoma. 2004 Mar;45(3):627-9.PMID: 15160930 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.

Hamaki T, Kami M, Kusumi E, Ueyama J, Miyakoshi S, Morinaga S, Mutou Y.

Am J Hematol. 2001 Dec;68(4):292-4.PMID: 11754421 [PubMed - indexed for MEDLINE]Related articles

[Reactivation of hepatitis B virus in patients with hematological neoplasms]

Takkenberg RB, Zaaijer HL, ten Cate DF, Biemond BJ, Jansen PL, Reesink HW.

Ned Tijdschr Geneeskd. 2009 May 9;153(19):926-31. Review. Dutch. No abstract available. PMID: 19489299 [PubMed - indexed for MEDLINE]Related articles

HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.

Sarrecchia C, Cappelli A, Aiello P.

J Infect Chemother. 2005 Aug;11(4):189-91.PMID: 16133710 [PubMed - indexed for MEDLINE]Related articles

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.

He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ.

Ann Hematol. 2008 Jun;87(6):481-5. Epub 2008 Feb 26.PMID: 18299831 [PubMed - indexed for MEDLINE]Related articles

Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.

Zell JA, Yoon EJ, Ignatius Ou SH, Hoefs JC, Chang JC.

Anticancer Drugs. 2005 Jan;16(1):83-5.PMID: 15613909 [PubMed - indexed for MEDLINE]Related articles

[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab]

Vives S, Sancho JM, Planas R, Ribera JM.

Med Clin (Barc). 2006 Jun 3;127(1):39. Spanish. No abstract available. PMID: 16796944 [PubMed - indexed for MEDLINE]Related articles

Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.

Miyagawa M, Minami M, Fujii K, Sendo R, Mori K, Shimizu D, Nakajima T, Yasui K, Itoh Y, Taniwaki M, Okanoue T, Yoshikawa T.

J Med Virol. 2008 Dec;80(12):2069-78.PMID: 19040281 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.

Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.

J Viral Hepat. 2006 Sep;13(9):591-6.PMID: 16907845 [PubMed - indexed for MEDLINE]Related articles

Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.

Sera T, Hiasa Y, Michitaka K, Konishi I, Matsuura K, Tokumoto Y, Matsuura B, Kajiwara T, Masumoto T, Horiike N, Onji M.

Intern Med. 2006;45(11):721-4. Epub 2006 Jul 3.PMID: 16819252 [PubMed - indexed for MEDLINE]Related articlesFree article

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.

Niscola P, Del Principe MI, Maurillo L, Venditti A, Buccisano F, Piccioni D, Amadori S, Del Poeta G.

Leukemia. 2005 Oct;19(10):1840-1. No abstract available. PMID: 16094417 [PubMed - indexed for MEDLINE]Related articles

Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report.

Ng HJ, Lim LC.

Ann Hematol. 2001 Sep;80(9):549-52.PMID: 11669307 [PubMed - indexed for MEDLINE]Related articles

From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients.

Zoppoli G, Bruzzone B, Caligiuri P, Picciotto A, Balleari E, Bruzzone A, Icardi G, Ghio R.

Br J Haematol. 2009 Mar;144(6):969-70. Epub 2008 Dec 12. No abstract available. Erratum in: Br J Haematol. 2009 Nov;147(3):411. Gabriele, Zoppoli [corrected to Zoppoli, Gabriele]; Bianca, Bruzzone [corrected to Bruzzone, Bianca]; Patrizia, Caligiuri [corrected to Caligiuri, Patrizia]; Antonino, Picciotto [corrected to Picciotto, Antonino]; Enrico, Balleari [corrected to Balleari, Enrico]; Andrea, Bruzzone[corrected to Bruzzone, Andrea]; Giancarlo, Icardi [corrected to Icardi, Giancarlo]; Riccardo, Ghio [corrected to Ghio, Riccardo]. PMID: 19120363 [PubMed - indexed for MEDLINE]Related articles